with 200 mM sucrose in PBS (pH 7.4) above the gel-liquid transition temperature of all of the lipids (~45°C) for 20 minutes (See Figure S1 for an example of the swollen lipid film).
For individual imaging, GUVs were harvested from the coverslip and diluted in 3x 200 mM glucose in PBS (pH 7.4). GUVs were allowed to settle in glucose for 15 minutes at 45°C and then anchored to coverslips functionalized with BSA-biotin. Functionalized coverslips were freshly cleaned and treated with BSA-biotin (1% w/v) for 1 hour at room temperature, leading to physiosorption of BSA on the glass surface. Coverslips were then washed with Milli-Q water and exposed to avidin (1 mg/ml) immediately prior to anchoring individual GUVs. Antibody binding and antagonist binding was performed at 37°C and all imaging was performed at 30°C.
3,4
Antibody labeling 5-HT 1A antibodies were equilibrated to room temperature and conjugated to NHSrhodamine in DMSO at 10x molar excess. Sodium bicarbonate was added as per manufacturer's instructions to raise the pH to 8.0. The solution was allowed to react for one hour at room temperature. After one hour antibodies were desalted using spin columns according the manufacturer's instructions. Labeled antibody UV-vis absorbance was read on a NanoDrop ND-1000 (Thermo Fisher, USA). Antibody concentration was determined to be 7.7 mg/mL and labeling efficiency was calculated to be 0.83.
Antibody Binding Assay
GUVs previously prepared for individual imaging were exposed to 1:1000 rhodaminelabeled 5-HT 1A antibodies at 37°C for 1 hour. GUVs were imaged before and after to track the increased intensity at vesicle surfaces as a result of successful antibody binding (see Figure S2 ). Samples were subsequently washed with 200 mM glucose in PBS to remove excess fluorescent antibody. GUVs were imaged at 491 nm and 561 nm excitation corresponding to 523 nm and 575 nm emission respectively.
Antagonist Binding Assay
GUVs anchored to a glass coverslips of observation chambers were exposed to 1 mM of 5HT1A-633-AN2, a fluorescent derivative of the 5-HT 1A antagonist NAN-190. The concentration is 1-log unit above the K d per product specification. Samples were incubated at 37°C for 10 minutes. GUVs were washed with 200 mM glucose in PBS to remove excess fluorophore and were imaged to observe antagonist binding at 491 nm and 640 nm excitation corresponding to 523 nm and 650 nm emission respectively.
Microscopy
Imaging was done on a TI-Eclipse inverted microscope (Nikon, Japan) equipped with a spinning-disc CSUX confocal head (Yokogawa, Japan) and a 16-bit Cascade II 512 EMCCD camera (Photometrics, USA). Excitation of fluorophores was done using 50 mW solid-state lasers at 491 nm, 561 nm, and 640 nm (Coherent Inc., Germany) at 200ms exposure time. All images were taken using a Plan-Apo 60x NA1.43 oil immersion Nikon objective. Z-stack images were separated by 0.5 µm steps. Temperature control during imaging was performed using a heating-cooling stage with a stability and accuracy of 0.1°C (Bioscience Tools, USA).
Image Processing
All images were processed and analyzed using ImageJ. Standard deviation projections of Z-stacks were produced using standard ImageJ stack tools. Fluorescent micrographs of GUVs using 491 nm excitation are shown using the ImageJ green lookup table, micrographs using 561 nm excitation are shown using the ImageJ red lookup table and all images using 640 nm excitation are shown using the ImageJ blue lookup table. All images are presented without any further processing adjustments or corrections and (with the exception of control images that show no objects) are scaled from minimum to maximum intensity. Images in which no objects could be discerned were adjusted to match intensity histogram of the rhodamine-band image in Figure 1C (Mean intensity: 1387.3, Standard Deviation: 3249.4, Minimum: 34.7, Maximum: 21711.7). The adjustment eliminated the artifactual apparent amplification of background noise that occurs if min-max scaling is applied to blank images. Images are presented as Z-stack projections unless otherwise specified. All other analysis was done using JMP.
Images of GUV yield from agarose hydration method
GUVs were labeled with 0.2 mol% ATTO-488-DPPE to facilitate fluorescent observation of vesicles. Upon rehydration of the lipid film on the agarose surface, vesicles could be seen to bud under the 491 nm excitation band ( Figure S1 ). There was no detected signal at 561 nm excitation, indicating that the ATTO-488 dye had no significant bleed-through into the fluorescent bands that were used to image the antibody. GUVs were harvested from coverslips and settled in observation chambers. The size of typical vesicles yielded from agarose swelling ranges from 1µm to 50µm. A representative histogram for POPC systems can be found in Figure S1 . This distribution is typical of all lipid system used in all studies described here. 
Antibody binding
Antibody binding could be observed prior to the induction of phase separation. GUVs were imaged prior to antibody exposure at both 491 nm and 561 nm excitation. After exposure to 1:1000 NHS-rhodamine conjugated 5-HT 1A polyclonal antibody for one hour at 37°C, GUVs were imaged and increased intensity at the edges (exterior) of vesicles was observed at 561 nm excitation. See Figure S2 and S3. 
Identification of Liquid Ordered Phase
In order to confirm the partitioning of ATTO-488-DPPE into the liquid disordered region of phase separated vesicles the bright and dark regions of GUVs were quantified. The liquid disordered phase is primarily made up of POPC or DOPC while the liquid ordered phase is primarily cholesterol and BSM and/or DPPC. We plotted ratios of bright pixels to total GUV size (in pixels) in micrographs as a function of lipid composition (see Figure S4C ). Furthermore vesicles fluorescently tagged with rhodamine-DPPE, which is known to partition into the liquid disordered phase, 5 were also fabricated and morphology of phase separated ATTO vesicles were compared. To quantify the regions of bright and dark in phase separated vesicles, representative images were thresholded to binary and the number of white pixels was compared to the number of black pixels each GUV. 1:1:3, 2:1:2, 5:1:4, and 3:6:11 POPC:BSM:Chol compositions (n = 4 for each composition) were used in order to span the phase separation envelope as previously described by Veatch et al. (see Figure S4A ).
3 Figure  S4B shows an example of an image made binary and C shows a plot of the ratio of bright pixels to total GUV area versus the composition in terms of liquid ordered-preferring (cholesterol and BSM) and disordered-preferring (POPC) lipids. The plot clearly shows that as the concentration of cholesterol and BSM is decreased in the system, the ratio of bright pixels to dark pixels increases. Since this system has previously been shown to exhibit liquid/liquid phase coexistence at the temperature we studied here, 4 the bright region can be identified as a liquid disordered phase while the dark region is a liquid ordered phase. Figure S5 shows images of phase-separated vesicles tagged with rhodamine-DPPE alongside phase separated vesicles of the same composition tagged with ATTO-488-DPPE. Rhodamine-DPPE has been previously reported to partition into the liquid disordered phase. 5 Therefore qualitative comparison of the morphologies of the vesicles makes it apparent that ATTO-488-DPPE partitions into the liquid disordered phase of vesicles. This further confirms the segregation of 5-HT 1A into the liquid disordered phase or bright region of phase separated GUVs. Figure S6 shows phase separation in GUVs with and without 5-HT 1A at phase-separating compositions in which the total concentration of cholesterol in the system has been varied from 10% to 30%. In all cases, the protein continues to segregate with the liquid disordered phase. In each triptych, excitation at 491 nm is on the left, 561 nm is in the center, and an overlay is on the right. Scale bars are 5 µm.
Phase separation at varying cholesterol concentrations

